Vtama vs Zoryve

Vtama: A once-daily steroid-free cream for plaque psoriasis. It can be used anywhere on the body, including the face and skin folds, and some people stay clear for months after stopping. Zoryve: A once-daily steroid-free cream for psoriasis, eczema and seborrheic dermatitis. It has no boxed warning and no limit on how long or how much you use it, which is unusual.

Reviewed by Dr. Schwarz, Board-Certified Dermatologist
Vtama — Header ImageRepresentative medication packaging labelled Zoryve, lying sideways on a white background.

Which one is right for you?

Choose Vtama if…

Choose for psoriasis or eczema anywhere on the body when you want a once-daily non-steroid with no time limit.

  • Psoriasis on the face or folds
  • You want to avoid steroid thinning
  • Once-daily use suits you

Choose Zoryve if…

Choose for psoriasis, eczema or seborrheic dermatitis when you want a once-daily non-steroid with no limit on time or area.

  • Psoriasis in folds or on the face
  • Seborrheic dermatitis of scalp or face
  • You want to avoid steroid side effects
Alternatives, not combined

Can you take them together?

Both are steroid-free creams for psoriasis and eczema. Most people use one or the other.

At a glance

● Vtama
● Zoryve
Type
Topical AhR agonist (tapinarof 1%)
Topical PDE4 inhibitor (roflumilast)
What it does
Calms inflammation and restores the skin barrier
Calms inflammation without a steroid
Best for
Plaque psoriasis and eczema, including face and folds
Psoriasis, eczema and seborrheic dermatitis
Prescription
Yes
Yes
Form
Cream
Cream or foam, 0.15% or 0.3%
How often
Once daily
Once daily
Course length
No time limit
No time limit
Time to results
8–12 weeks
4–8 weeks
Main side effect
Folliculitis
Rarely any; mild diarrhea or headache
Blood tests
None
None
Pregnancy
Check with your clinician
Check with your clinician
Cost
High; brand only
High; brand only

What it treats

Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.

Evidence level
Vtama
Zoryve
Strong evidenceMost established uses
Two thick, sharply bordered plaques on a knee on fair light skin. They are salmon-pink to red with loose silvery-white scale on top.

Psoriasis

Clears plaques without steroids.
Extreme close-up of light skin in an active eczema flare, too close to tell which part of the body it is. Blotchy pink-red inflammation covers the whole frame with no clear edge, with small raised bumps, fine dry scale and a few fresh scratch marks.

Eczema

Reduces itch and redness.
Two thick, sharply bordered plaques on a knee on fair light skin. They are salmon-pink to red with loose silvery-white scale on top.

Psoriasis

Clears plaques, including in folds.
Salmon-pink patches with fine greasy yellowish scale in the crease beside the nose and through the eyebrow on fair skin, with soft edges that fade into normal skin.

Seborrheic Dermatitis

Foam reduces scalp and face scale.
Moderate evidenceSome supportive research
—
Extreme close-up of light skin in an active eczema flare, too close to tell which part of the body it is. Blotchy pink-red inflammation covers the whole frame with no clear edge, with small raised bumps, fine dry scale and a few fresh scratch marks.

Eczema

Reduces itch and redness.
Little evidence
Redness and fine superficial vessels across a light-skinned cheek and nose.

Rosacea

Not studied for rosacea.
Redness and fine superficial vessels across a light-skinned cheek and nose.

Rosacea

Not studied enough.
Not effective
—
Inflamed acne on light skin. The spots sit in a patch of pink, and the ring of redness around each one is easy to see. A few have a yellow-white head, and the skin between them is dry and flaking.

Acne

No role in acne.
Can make it worse
Inflamed acne on light skin. The spots sit in a patch of pink, and the ring of redness around each one is easy to see. A few have a yellow-white head, and the skin between them is dry and flaking.

Acne

Folliculitis and acne are possible side effects.
—
How it works

Vtama

Vtama. Tapinarof activates a skin-regulating receptor. 1. Activates AhR: Binds a receptor that helps regulate skin-cell behavior. 2. May rebalance inflammation: Changes in immune signaling may help calm skin. 3. May support the skin barrier: Changes in barrier proteins may help skin function.
Open full-size diagram
Diagram explanation and sources

Activates AhR: Binds a receptor that helps regulate skin-cell behavior. May rebalance inflammation: Changes in immune signaling may help calm skin. May support the skin barrier: Changes in barrier proteins may help skin function.

Tapinarof is an AhR agonist; the specific therapeutic mechanisms are unknown. Anti-inflammatory and barrier effects are proposed from experimental evidence and are explicitly qualified.

Source 1 · Source 2

Zoryve

Zoryve. Roflumilast turns down inflammation inside skin. 1. Blocks PDE4: Inhibits an enzyme that breaks down cAMP. 2. Raises cAMP inside cells: Preserves a signal involved in regulating inflammation. 3. Helps inflamed skin settle: Redness, scaling, and itch can improve.
Open full-size diagram
Diagram explanation and sources

Blocks PDE4: Inhibits an enzyme that breaks down cAMP. Raises cAMP inside cells: Preserves a signal involved in regulating inflammation. Helps inflamed skin settle: Redness, scaling, and itch can improve.

PDE4 inhibition and increased intracellular cAMP are established. The exact link to clinical improvement is not fully defined; this is a simplified overview, not every downstream pathway.

Source 1

How you take it

Treatment plan

When to Apply: Once a day, at whatever time you will remember. A thin layer over the plaques, rubbed in. It can go on the face, eyelids, armpits, groin and under the breasts, which sets it apart from a steroid. Wash your hands afterwards unless your hands are being treated.

How to Start: Once daily from day one, on every plaque you want treated. No ramp-up, and no cap on how much of the body can be covered, so it does not have to be rationed the way a strong steroid does.

If It Irritates: Small red bumps around hair follicles are the most common problem and usually appear in the first few weeks. Most are not infection and often settle without stopping. Stinging or a rash where you applied it is the other pattern, and that one is worth showing your doctor, because a true contact allergy means stopping.

If It’s Not Working: There is one strength, so there is nothing to increase. Give it a full twelve weeks. If plaques are still thick then, the conversation is about adding something else, phototherapy, or moving to a tablet or injection.

When to Apply: Once a day, at a time you will remember. A thin layer over the affected skin, rubbed in. It can go on the face, eyelids, armpits, groin and under the breasts. Moisturizer and sunscreen can go on top once it has absorbed. For the foam, part the hair and apply to the scalp rather than the hair.

How to Start: Once daily from day one, on every affected area. No build-up period, no strength to work through. The common mistake is treating only the worst patches, which makes the result look worse than it is.

If It Irritates: Stinging or mild burning where you apply it settles within a week or two, and moisturizing beforehand helps. Loose stools, headache or feeling slightly sick in the first weeks is a known, usually mild effect of the drug — tell your doctor if it does not pass.

If It's Not Working: Give it 8 weeks of daily use, though itch often eases much sooner. If plaques are unchanged at 8 weeks, the options are a strong steroid for the thickest areas while keeping roflumilast on the rest, adding a vitamin D cream, or moving to light treatment or a systemic medicine. Twice a day does not help.

Monitoring

No blood tests are required. There is nothing to check on a lab report, which is one of the practical arguments for a topical over a tablet.

Monitoring is a look at the skin and a conversation, usually at about twelve weeks. Two things get asked about: folliculitis, and whether it is a few bumps or enough to be a problem; and whether the treated skin has become itchy and inflamed in a new way, which points to contact dermatitis rather than psoriasis.

Long term there is no organ risk to track and no skin thinning to watch for, so there is no maximum duration. What is genuinely not known yet is what many years of continuous use looks like, because the drug is recent. A common pattern is to treat until clear, stop, and restart when plaques come back.

No routine blood tests, no boxed warning, no limit on how much body surface you treat, no maximum duration.

What is worth watching has nothing to do with skin. The oral form causes diarrhea, nausea, appetite loss and weight loss in a meaningful number of people, and has been linked to low mood and, rarely, suicidal thoughts. The cream and foam give much lower blood levels, so these are far less common — but they are on the label and your doctor will ask. If you lose weight without trying, or your mood drops, say so.

Otherwise monitoring is a review of whether it is working, around 8 weeks at first. Your doctor will check your history for liver problems, since severe liver impairment rules it out.

When you’ll see results

Approximate windows, not promises.

● Vtama
● Zoryve
First few minutes

First few minutesApplying it: A thin layer once a day on the plaques.

First few minutesApplying it: Once a day. Possible stinging where you apply it, which usually settles.

Weeks 1 to 4

Weeks 1 to 4Starting: Scale and roughness ease before the redness does, often by week four. Folliculitis shows up now if it is going to, usually small tender bumps in hair-bearing areas.

Weeks 4 to 8

Weeks 4 to 8Working: Plaques flatten and shrink, and color fades from red toward pink or brown.

Weeks 4 to 8Working: Plaques flatten, scale drops away and redness fades. Week 8 is the fair point to judge plaque psoriasis; eczema and seborrheic dermatitis declare themselves around four weeks. Thinner plaques respond faster.

Weeks 8 to 12

Weeks 8 to 12Judge it here: Trials measured their main result at twelve weeks, and many people were still improving then. A meaningful minority reached clear or almost clear skin — a realistic target, not a promise.

After stopping

After stoppingRemission: Unlike a steroid, it does not usually rebound. People who cleared completely often stayed clear for months before restarting.

Week 1

Week 1Adjusting: A few people get diarrhea, headache or mild nausea. These come from the drug rather than the skin, and are far less common with the cream than the oral version.

Weeks 1 to 2

Weeks 1 to 2First change: Itch improves first. In seborrheic dermatitis, flaking and redness often start easing here too.

Folds, face and eyelids

Folds, face and eyelidsWhere it stands out: These sites absorb steroids quickly and thin fast, so a once-daily option with no time limit changes how they are managed.

After clearing

After clearingHolding: No thinning, so no reason to stop once skin is clear. Many people continue daily; some drop to a few times a week.

Side effects

Sorted by what to do about them.

Vtama

Zoryve

Common
Common
  • Folliculitis (small red bumps at hair follicles)
  • Itch, headache
Common
  • Rarely any
  • Mild diarrhea, headache
Tell your doctor
Tell your doctor
  • Acne-like spots that persist
Tell your doctor
  • Application-site pain
Stop and get care
Stop and get care
  • Spreading painful infection
Stop and get care
  • Swelling or trouble breathing

Safety and who should avoid it

Pregnancy
Ask first
Discuss with your clinician.
Ask first
Discuss with your clinician.
Breastfeeding
Ask first
Discuss with your clinician.
Ask first
Discuss with your clinician.
Children
2 and older
Approved from 2 for eczema.
2 and older
Approved from 2 for some uses.
Monitoring
None
Review at 12 weeks.
None
Review at 8 weeks.
Key interactions
None known
—
Check
Some enzyme inhibitors and oral roflumilast.
Other cautions
Use care
Folliculitis-prone skin.
Avoid
Moderate to severe liver disease.

Cost and getting it

Getting it and cost

Brand only, with no generic. It is one of the more expensive topicals for psoriasis and costs far more than a generic steroid or generic calcipotriene.

Coverage varies and prior authorization is common; plans frequently want to see a topical steroid, and often a vitamin D analog, tried first. Manufacturer copay cards exist and the terms change, so check the current one.

Because a tube covers only so much, cost climbs quickly with widespread psoriasis, which is one of the main reasons people end up on a tablet or injection instead.

This is the main reason people do not end up on it. Roflumilast is brand only with no generic, and a tube runs to several hundred dollars or more. Generic steroid creams cost a small fraction of that.

A prior authorization is close to routine. Most plans want to see that a topical steroid was tried and either failed or is not appropriate — the fold, face and eyelid argument usually succeeds, because those are exactly the places long-term steroid use causes harm. Some plans also want a vitamin D cream tried first. Denials are common on the first attempt and often overturned on appeal, so push back.

The manufacturer runs a copay program that can cut the cost substantially with commercial insurance, plus patient assistance for people who qualify. Terms change often. People on government insurance generally cannot use copay cards, which is a real gap.

One practical note: cost is per tube and psoriasis treatment is open-ended, so ask about the largest tube your plan will cover — the price per gram is usually better.

When you stop

Comes back?
Some people stay clear for months after stopping.
Plaques and scale return gradually after stopping.
Taper needed?
No.
No.
After the last dose
Restart if plaques return.
Restart if it returns.

Common questions

Vtama:Is it a steroid?

No. It works on a different switch inside the skin cell, the aryl hydrocarbon receptor. That is why there is no time limit and no skin thinning.

Vtama:Can I put it on my face?

Yes — approved for the face and skin folds, one of its main advantages over a steroid.

Vtama:What are the little bumps I am getting?

Most likely folliculitis — small red bumps around hair follicles where you applied it. The most common side effect in the trials, at roughly one in five people, usually mild, and most carried on.

Vtama:How long before I know if it works?

Give it twelve weeks. Some change usually shows by four.

Vtama:Can I stop once I am clear?

That is a normal way to use it. In the long-term study, many who cleared completely stayed clear for months, then restarted when plaques returned.

Vtama:Does it work for eczema too?

Yes, it is also approved for atopic dermatitis, in adults and in children from age two.

Zoryve:Is roflumilast a steroid?

No. It blocks an enzyme called PDE4 inside inflammatory cells. It does not thin skin, which is why it can go on the face, eyelids and folds without a time limit.

Zoryve:How long can I use it?

There is no fixed maximum. The rule about stopping after a few weeks comes from steroid creams. Long-term daily use with regular review is normal.

Zoryve:Why is it once a day when most creams are twice?

Once daily is what the trials tested. Twice does not clear skin faster and makes stomach side effects more likely.

Zoryve:Will it upset my stomach?

Usually not. Diarrhea, nausea and headache are listed because they can happen, and are common with the oral version used for lung disease. Blood levels from the cream and foam are much lower.

Zoryve:What is the difference between the cream and the foam?

The drug is the same. The foam lets it spread through hair and over the scalp, and it is the form used for seborrheic dermatitis. The 0.3% cream is for psoriasis and the 0.15% cream for eczema.

Zoryve:Why is there still a mark where the plaque was?

Clearing inflammation often leaves a dark or pale patch. Not active disease, and it fades over months. It shows up more on deeper skin tones.

Zoryve:Can I use it with a steroid cream?

A common approach — a strong steroid for the thickest patches, roflumilast for the face, folds and the rest. Plan it with your doctor rather than layering both on one spot.

Dermapedia on YouTube